Theodora Adamantidi

Ms. Theodora Adamantidi

Chemistry, Democritus University of Thrace, Kavála, Anatolikí Makedonía kai Thráki, Greece
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2024 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
PDF file
Alexandros TsouprasAlexandros Tsoupras
Alexandros Tsoupras
Theodora AdamantidiTheodora Adamantidi
Theodora Adamantidi
MFMarios Argyrios Finos
Marios Argyrios Finos
APAthanassios Philippopoulos
Athanassios Philippopoulos
PDParaskevi Detopoulou
Paraskevi Detopoulou
CDConstantinos A. Demopoulos
Constantinos A. Demopoulos
Since 2000s, we have outlined the multifaceted role of inflammation in several aspects of cancer, via specific inflammatory mediators, including the platelet activating factor (PAF) and PAF-receptor (PAFR) related signaling, which affect important inflammatory junctions and cellular interactions that are associated with tumor-related inflammatory manifestations. It is now well established that disease-related unresolved chronic inflammatory responses can promote carcinogenesis. At the same time, tumors themselves are able to promote their progression and metastasis, by triggering an inflammation-related vicious cycle, in which PAF and its signaling play crucial role(s), which usually conclude in tumor growth and angiogenesis. In parallel, new evidence suggests that PAF and its signaling also interact with several inflammation-related cancer treatments by inducing an antitumor immune response or, conversely, promoting tumor recurrence. Within this review article, the current knowledge and future perspectives of the implication of PAF and its signaling in all these important aspects of cancer are thoroughly re-assessed. The potential beneficial role of PAF-inhibitors and natural or synthetic modulators of PAF-metabolism against tumors, tumor progression and metastasis are evaluated. Emphasis is given to natural and synthetic molecules with dual anti-PAF and anti-cancer activities (Bio-DAPAC-tives), with proven evidence of their antitumor potency through clinical trials, as well as on metal-based anti-inflammatory mediators that constitute a new class of potent inhibitors. The way these compounds may promote anti-tumor effects and modulate the inflammatory cellular actions and immune responses is also discussed. Limitations and future perspectives on targeting of PAF, its metabolism and receptor, including PAF-related inflammatory signaling, as part(s) of anti-tumor strategies that involve inflammation and immune response(s) for an improved outcome, are also evaluated.

18 November 2024 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MPMaria Aliki Papikinou
Maria Aliki Papikinou
Konstantinos PavlidisKonstantinos Pavlidis
Konstantinos Pavlidis
PCPaschalis Cholidis
Paschalis Cholidis
DKDimitrios Kranas
Dimitrios Kranas
Theodora AdamantidiTheodora Adamantidi
Theodora Adamantidi
Alexandros TsouprasAlexandros Tsoupras
Alexandros Tsoupras
Fungi play a fundamental role in the marine environment, being promising producers of bioactive molecules in the pharmacological and industrial fields, which have demonstrated potential health benefits against cardiovascular and other chronic diseases. This review pertains to the analysis of the lipid compositions across various species of marine fungi and their constantly discovered substances, as well as their anti-inflammatory, antioxidant, and antithrombotic effects. The health-promoting aspects of these microorganisms will be explored, through the investigation of several mechanisms of action and interference of their bioactives in biochemical pathways. Despite exceptional results in this field, the potential of marine microorganisms remains largely unexplored due to the limited number of specialists in marine microbiology and mycology, a relatively recent science with significant contributions and potential in biodiversity and biotechnology.

21 July 2024 in Processes
Verified
Journal Article
Open access
PDF file
Theodora AdamantidiTheodora Adamantidi
Theodora Adamantidi
EPEllie Panoutsopoulou
Ellie Panoutsopoulou
ESEvangelia Stavrakoudi
Evangelia Stavrakoudi
PTPanagiota Tzevelekou
Panagiota Tzevelekou
Nikolaos C. KokkinosNikolaos C. Kokkinos
Nikolaos C. Kokkinos
The impact of COVID-19’s unexpected outbreak forced the scientific community to seek alternative treatment methods in order to overcome the hindrance of traditional medicine in terms of alleviating the symptoms of this virus. Erythromycin, which was introduced in 1952, is an antibiotic that is reported to pose as an effective substitute medication for various ailments such as skin, respiratory, bone, and female reproductive conditions, and cancer, as well as the newly added COVID-19. The importance of both the erythromycin molecule and the catalyst of its production, namely P450eryF of the cytochrome P450 family, in many health-concerned and environmentally related applications, has led several countries, the World Health Organization (WHO) and the health industry to recruit and cooperate with numerous universities and institutions, in an attempt to tackle the demand for efficient antibiotics. The aim of this study is to discuss and further analyze the overall structure and catalytic mechanism of erythromycin’s synthesis and industrial production, in order to gain a better comprehension of this molecule’s significance and value in the pharmaceutical field. This was carried out through the citation of the current production rates per country and the latest statistics and published patents. As implied in this manuscript, the demand for an increase and improvement in the production of erythromycin and its antibiotic derivatives should be globally promoted to deliver more effective results against infectious diseases, such as COVID-19.

11 December 2024 in Marine Drugs
Verified
Journal Article
Open access
PDF file
PCPaschalis Cholidis
Paschalis Cholidis
DKDimitrios Kranas
Dimitrios Kranas
ACAngeliki Chira
Angeliki Chira
ΕΓΕΥΑΓΓΕΛΙΑ ΑΙΚΑΤΕΡΙΝΗ ΓΑΛΟΥΝΗ
ΕΥΑΓΓΕΛΙΑ ΑΙΚΑΤΕΡΙΝΗ ΓΑΛΟΥΝΗ
Theodora AdamantidiTheodora Adamantidi
Theodora Adamantidi
Alexandros TsouprasAlexandros Tsoupras
Alexandros Tsoupras
Marine animals, especially shrimp species, have gained interest in research, due to the fact that they contain a plethora of biomolecules, specifically lipids, which have been proven to possess many health benefits in various diseases linked to chronic inflammation or other exogenous factors. This review refers to the lipid composition of a large number of shrimp species, as well as the effects that can alternate the lipid content of these crustaceans. Emphasis is given to the potent anti-inflammatory, antioxidant, and antithrombotic properties of shrimp bioactives, as well as the effects that these bioactives hold in other diseases, such as cancer, diabetes, neurodegenerative disorders, and more. The various health-promoting effects deriving from the consumption of shrimp lipid bioactives and the usage of products containing shrimp lipid extracts are also addressed in this study, through the exploration of several mechanisms of action and the interference of shrimp lipids in these biochemical pathways. Nevertheless, further research on this cultivatable edible species is needed, due to their existing limitations and future prospects which are discussed in this paper.